Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.
Denardo, S J
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. [electronic resource] - Anticancer research - 4011-8 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0250-7005
Adenocarcinoma--drug therapy
Animals
Antineoplastic Agents, Phytogenic--therapeutic use
Breast Neoplasms--drug therapy
Combined Modality Therapy
Female
Heterocyclic Compounds--pharmacokinetics
Humans
Mice
Mice, Nude
Oligopeptides--pharmacokinetics
Paclitaxel--therapeutic use
Radioimmunotherapy
Time Factors
Transplantation, Heterologous
Tumor Cells, Cultured
Yttrium--pharmacokinetics
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. [electronic resource] - Anticancer research - 4011-8 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0250-7005
Adenocarcinoma--drug therapy
Animals
Antineoplastic Agents, Phytogenic--therapeutic use
Breast Neoplasms--drug therapy
Combined Modality Therapy
Female
Heterocyclic Compounds--pharmacokinetics
Humans
Mice
Mice, Nude
Oligopeptides--pharmacokinetics
Paclitaxel--therapeutic use
Radioimmunotherapy
Time Factors
Transplantation, Heterologous
Tumor Cells, Cultured
Yttrium--pharmacokinetics